Application of microRNAs in the diagnosis and monitoring of pediatric germ cell tumors: Kazakh experience

MicroRNA-profiling of miR-371~373- and miR-302/367-clusters in serum and cerebrospinal fluid identify patients with intracranial germ cell tumors

(2022) Stefan Schönberger et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Serum tumour markers in germ cell tumours: from diagnosis to cure

(2021) Paolo Pedrazzoli et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

The combination of microRNA-371a-3p and 375-5p can distinguish viable germ cell tumor and teratoma from necrosis in postchemotherapy retroperitoneal lymph node dissection specimens

(2021) Lara Kremer et al.   Translational Andrology and Urology

Application of miRNAs in the diagnosis and monitoring of testicular germ cell tumours

(2020) Kristian Almstrup et al.   Nature Reviews Urology

Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study

(2019) Klaus-Peter Dieckmann et al.   JOURNAL OF CLINICAL ONCOLOGY

Developing a Highly Specific Biomarker for Germ Cell Malignancies: Plasma miR371 Expression Across the Germ Cell Malignancy Spectrum

(2019) Lucia Nappi et al.   JOURNAL OF CLINICAL ONCOLOGY

miR-371a-3p, miR-373-3p and miR-367-3p as Serum Biomarkers in Metastatic Testicular Germ Cell Cancers Before, During and After Chemotherapy

(2019) Ximena Rosas Plaza et al.   Cells

Serum Level of microRNA-375-3p Is Not a Reliable Biomarker of Teratoma

(2019) GAZANFER BELGE et al.   IN VIVO

Identification and Validation Model for Informative Liquid Biopsy-Based microRNA Biomarkers: Insights from Germ Cell Tumor In Vitro, In Vivo and Patient-Derived Data

(2019) João Lobo et al.   Cells

Serum miRNA Predicts Viable Disease after Chemotherapy in Patients with Testicular Nonseminoma Germ Cell Tumor

(2018) Ricardo Leão et al.   JOURNAL OF UROLOGY

Integrated Molecular Characterization of Testicular Germ Cell Tumors

(2018) Hui Shen et al.   Cell Reports

Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific New Biomarker for Germ Cell Tumours

(2017) Klaus-Peter Dieckmann et al.   EUROPEAN UROLOGY

microRNA-371a-3p as informative biomarker for the follow-up of testicular germ cell cancer patients

(2017) Ton van Agthoven et al.   CELLULAR ONCOLOGY

A pipeline to quantify serum and cerebrospinal fluid microRNAs for diagnosis and detection of relapse in paediatric malignant germ-cell tumours

(2015) Matthew J Murray et al.   BRITISH JOURNAL OF CANCER

Circulating Serum miRNA (miR-367-3p, miR-371a-3p, miR-372-3p and miR-373-3p) as Biomarkers in Patients with Testicular Germ Cell Cancer

(2015) Isabella Syring et al.   JOURNAL OF UROLOGY

Biology of childhood germ cell tumours, focussing on the significance of microRNAs

(2014) M. J. Murray et al.   Andrology

MicroRNA miR-371a-3p in serum of patients with germ cell tumours: evaluations for establishing a serum biomarker

(2014) M. Spiekermann et al.   Andrology

Targeted serum miRNA (TSmiR) test for diagnosis and follow-up of (testicular) germ cell cancer patients: A proof of principle

(2013) Ad J.M. Gillis et al.   Molecular Oncology

Serum Levels of MicroRNAs miR-371-3: A Novel Class of Serum Biomarkers for Testicular Germ Cell Tumors?

(2012) Gazanfer Belge et al.   EUROPEAN UROLOGY

Identification of MicroRNAs From the miR-371∼373 and miR-302 Clusters as Potential Serum Biomarkers of Malignant Germ Cell Tumors

(2010) Matthew J. Murray et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Malignant Germ Cell Tumors Display Common MicroRNA Profiles Resulting in Global Changes in Expression of Messenger RNA Targets

(2010) Roger D. Palmer et al.   CANCER RESEARCH